🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, asserting the firms hid alleged dangers that the pain reliever posed to children's neurological development.

This legal action follows a month after President Donald Trump promoted an unverified association between taking Tylenol - alternatively called acetaminophen - during pregnancy and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he said they "betrayed America by making money from pain and marketing drugs ignoring the potential hazards."

Kenvue asserts there is lacking scientific proof connecting Tylenol to autism.

"These corporations misled for generations, intentionally threatening countless individuals to boost earnings," the attorney general, from the Republican party, declared.

The company commented that it was "very worried by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its official site, Kenvue also said it had "continuously evaluated the applicable studies and there is no credible data that shows a verified association between consuming paracetamol and autism."

Organizations speaking for doctors and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the primary component in acetaminophen - is one of the few options for pregnant women to treat discomfort and elevated temperature, which can create major wellness concerns if not addressed.

"In multiple decades of studies on the consumption of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the usage of acetaminophen in any stage of gestation causes brain development issues in children," the association commented.

The court filing references current declarations from the former administration in arguing the medication is reportedly hazardous.

Recently, Trump generated worry from public health officials when he told expectant mothers to "struggle intensely" not to consume acetaminophen when unwell.

Federal regulators then published an announcement that doctors should think about restricting the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism in children has not been established.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had promised in April to conduct "extensive scientific investigation" that would determine the source of autism in a short period.

But authorities warned that identifying a sole reason of autism - thought by researchers to be the result of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and condition that influences how persons experience and interact with the environment, and is recognized using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is running for US Senate - claims Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

The case attempts to require the corporations "destroy any marketing or advertising" that asserts acetaminophen is secure for expectant mothers.

The court case mirrors the grievances of a collection of guardians of minors with autism spectrum disorder and ADHD who filed suit against the makers of Tylenol in recently.

A federal judge dismissed the case, stating research from the family's specialists was inconclusive.